SARASOTA, Fla., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for…
Modified intent-to-treat group demonstrated +22.7 point (p<0.0001) treatment effect in the mean Bayley-III cognitive raw score compared to natural history…
NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to developing medicines…
MALVERN, Pa., Feb. 05, 2025 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"),…
This New Edutainment Tool for Families is now Available on iOS (iPhone and iPad) and Android phones CHICAGO, Feb. 4,…
SAN DIEGO, Feb. 4, 2025 /PRNewswire/ -- Zafrens, a pioneering biotech company transforming drug discovery, welcomes imec.xpand to its Series…
• This latest research builds upon the growing body of evidence demonstrating the unique impact of Brainomix's AI-powered software to…
OSLO, Norway, Feb. 4, 2025 /PRNewswire/ -- The Norwegian browser maker Opera [NASDAQ: OPRA] is introducing Opera Air, the first browser…
ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced…
Acceptance reflects the high interest of the SIR scientific committee on the emerging role of endovascular roboticsBRAINTREE, Mass., Feb. 04,…